Human breast carcinoma cells express type IIIL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo
P. Leland et al., Human breast carcinoma cells express type IIIL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo, MOL MED, 6(3), 2000, pp. 165-178
Citations number
50
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
Background: Human breast carcinoma cell lines express high-affinity interle
ukin-4 receptors (IL-4R). We examined the expression and structure of these
receptors on primary and cultured breast carcinoma cell lines and normal b
reast epithelial cells. We also tested the antitumor activity in vitro and
in vivo of a fusion protein comprised of circular permuted IL-4 and truncat
ed Pseudomonas exotoxin, termed IL-4(38-37)-PE38KDEL.
Materials and Methods: Eight different primary cell cultures and cell lines
of human breast carcinomas were examined for the expression of IL-4R by ra
diolabeled binding, reverse transcription polymerase chain reaction (RT-PCR
) and Northern analyses, and subunit structure by crosslinking studies. The
antitumor activity of IL-4 toxin was tested in vitro by cytotoxicity assay
s and in vivo in a xenograft model in immunodeficient animals.
Results: I-125-IL-4 specifically bound to primary cell cultures and cell li
nes with a Iid ranging between 0.2 and 1 nM. Breast tumor cells were found
to express IL-4R beta and IL-13R alpha' chains, but not IL-2R gamma(c) chai
n. These cells were highly sensitive to the cytotoxic effect of IL-4(38-37)
-PE38KDEL. The IC,, (concentration inhibiting protein synthesis by 50%) ran
ged between approximately 0.005-1.5 nM. A normal breast epithelial cell cul
ture was not sensitive to the cytotoxic activity of IL-4(38-37)PE38KDEL. MD
A-MB231 human breast carcinoma cell line formed a rapidly growing tumor in
nude mice. Intratumor and intraperitoneal administration of IL-4(38-37)-PE3
8KDEL caused a dose dependent regression of established tumors. A control t
oxin, anti-Tac(Fv)-PE38KDEL, targeted to the IL-2 receptor a chain did not
cause regression of these tumors. Conclusions: These results suggest that I
L-4(38-37)-PE38KDEL may be a useful agent for targeting of IL-4 receptor po
sitive human breast carcinomas and further studies should be performed to e
xplore fully its potential.